Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Jiedu Zhongyao Keli is a Traditional Chinese Medicine (TCM) formula, typically prepared in granule form, that aims to "tonify kidney" (补肾) and "detoxify" (解毒), often also incorporating ingredients to "strengthen spleen" (健脾). It is a multi-herb combination used primarily as an adjuvant therapy in oncology, particularly for colorectal cancer (CRC). The formula is believed to alleviate chemotherapy-related side effects, improve patient quality of life, and enhance survival outcomes. Its mechanism of action is complex and multi-faceted, involving the regulation of immune and inflammatory response pathways, modulation of macrophage immune infiltration, and effects on various signaling pathways such as MAPK, PI3K-Akt, and HIF-1. It has also been shown to influence the expression of certain plasma proteins and reduce lncRPPH1 in tumor-derived extracellular vesicles, thereby blocking M2-type macrophage polarization and preventing metastasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Jiedu Zhongyao Keli.